Reuters | Dec 02, 2020 10:12
(Adds comments, updates prices)
* Britain approves Pfizer-BioNTech's COVID-19 vaccine
* Interactive graphic tracking global spread of coronavirus:
* https://tmsnrt.rs/3aIRuz7 in an external browser
By Nakul Iyer
Dec 2 (Reuters) - Gold steadied on Wednesday as investors
were cautious over the passage of a U.S. stimulus package, while
markets cheered UK's approval of the Pfizer COVID-19 vaccine,
limiting bullion's upside.
Britain became the first country in the world on Wednesday
to approve Pfizer-BioNTech's COVID-19 vaccine, which will be
rolled out from early next week. Spot gold XAU= was unchanged at $1,814.80 per ounce by
0826 GMT. U.S. gold futures GCv1 fell 0.1% to $1,817.70.
Top Senate Republican Mitch McConnell urged the U.S.
Congress to pass a $1.4 trillion spending bill including
coronavirus stimulus, while some senators and House members
proposed relief measures worth $908 billion. "There's a little bit of uncertainty over the stimulus deal
to go through, and given it's at the lower end of the scale, it
is not super supportive," said Stephen Innes, chief global
market strategist at financial services firm Axi.
Although talks are a step in the right direction on the
fiscal spending front and signal further co-operation likely
ahead, stimulus efforts are well below what the market was
hoping for, Innes added.
Non-yielding gold is viewed as a hedge against inflation
likely to result from stimulus. Bullion pared early losses after the New York Times reported
U.S. President-elect Joe Biden will not immediately act to
remove the Phase 1 trade agreement, which President Donald Trump
inked with China. Gold is also seen as a hedge against political and economic
"Gold must remain persistently above its 200-day simple
moving average in order to assuage doubts over the integrity of
its upwards trend," said FXTM market analyst Han Tan.
In other metals, silver XAG= fell 0.7% to $23.85 an ounce.
Platinum XPT= dropped 0.4% to $996.07 and palladium XPD=
rose 0.2% to $2,410.84.
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Get free real time quotes, charts and alerts on stocks, indices, currencies, commodities and bonds. Get free top of the line technical analysis/predictors.
More content, faster quotes and charts, and a smoother experience is available only on the App.